| 2022/05/31 12:32:19 | |
|---|---|
| Price | |
| 206.2000 USD | |
| Difference | 3.64% (7.24) |
General attributes
| ISIN | US09062X1037 |
| Symbol | BIIB |
| Exchange | London Stock Exchange |
| Currency | USD |
| Sector | - |
| Security type | Stock |
| Market cap (m) | 30,683 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - (0) |
| Ask (Ask size) | - (0) |
| Open | 206.2000 USD |
| High | 206.2000 USD |
| Low | 206.2000 USD |
| Close (prev. day) | 198.96 USD |
| VWAP | 206.19998 USD |
| Volume (pcs) | 4,013 |
| Trading volume | 827,480.52 |
| Number of trades | 1 |
| Last size | 4,013 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: BIOGEN IDEC INC. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2022/08/08 |
|
Global Equity Ratings |
|
| 2022/07/25 |
|
Global Equity Ratings |
|
| 2022/07/19 |
|
Global Equity Ratings |
|
| 2022/06/29 |
|
Global Equity Ratings |
|
| 2022/05/25 |
|
Global Equity Ratings |
|
| 2022/05/31 12:32:19 | |
|---|---|
| Price | |
| 206.2000 USD | |
| Difference | 3.64% (7.24) |
General attributes
| ISIN | US09062X1037 |
| Symbol | BIIB |
| Exchange | London Stock Exchange |
| Currency | USD |
| Sector | - |
| Security type | Stock |
| Market cap (m) | 30,683 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - (0) |
| Ask (Ask size) | - (0) |
| Open | 206.2000 USD |
| High | 206.2000 USD |
| Low | 206.2000 USD |
| Close (prev. day) | 198.96 USD |
| VWAP | 206.19998 USD |
| Volume (pcs) | 4,013 |
| Trading volume | 827,480.52 |
| Number of trades | 1 |
| Last size | 4,013 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | - | - | - |
| Perf (abs.) | - | - | - |
| Beta | 0.84 | 0.81 | 0.89 |
| Volatility | 3.65 | 3.68 | 32.82 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | - USD (31) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 26.9550 USD (946) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 27.3809 USD (369) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 36.8875 USD (682) |
| YTD High | date | 233.8100 USD (2022/01/19) |
| YTD Low | date | 196.5000 USD (2022/05/06) |
| 52 Weeks High | date | 339.0500 USD (2021/08/12) |
| 52 Weeks Low | date | 196.5000 USD (2022/05/06) |
All listings for BIOGEN IDEC INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2022/08/12 | 17:35 | 215.70 EUR | 0.00 | 5 |
| Vienna Stock Exchange | 2022/08/12 | 17:32 | 215.90 EUR | 0.00 | 2 |
| Tradegate | 2022/08/12 | 19:41 | 215.80 EUR | 0.03 | 6 |
| Stuttgart | 2022/08/12 | 19:06 | 215.05 EUR | 0.00 | 3 |
| SIX Swiss Exchange | 2019/07/02 | 17:35 | 232.00 CHF | 0.00 | 1 |
| Nasdaq | 2022/08/12 | 19:45 | 222.01 USD | 74.73 | 10,949 |
| Munich | 2022/08/12 | 08:00 | 212.10 EUR | 0.00 | 1 |
| London Stock Exchange | 2022/05/31 | 12:32 | 206.2000 USD | 0.83 | 1 |
| Hanover | 2022/08/12 | 08:01 | 212.10 EUR | 0.00 | 1 |
| Hamburg | 2022/08/12 | 08:01 | 212.10 EUR | 0.00 | 1 |
| Frankfurt | 2022/08/12 | 15:33 | 213.25 EUR | 0.01 | 3 |
| Duesseldorf | 2022/08/12 | 19:00 | 215.55 EUR | 0.00 | 9 |
| Berlin | 2022/08/12 | 19:35 | 215.85 EUR | 0.00 | 16 |
Company Logo
Contact Details
| BIOGEN INC. |
| - - |
| 225 Binney Street - 02142 Cambridge |
| Telefon: 1-617-679-2000 |
| Fax: - |
| E-mail: info@biogen.com |
PDF Downloads
| Company report: BIOGEN IDEC INC. | |
Company Profile
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA. |
Members of Management Board
| Stelios Papadopoulos | Chairman of Board of Directors |
| Alexander Denner | Member of Board of Directors |
| Eric Rowinsky | Member of Board of Directors |
| Maria Freire | Member of Board of Directors |
| Richard Mulligan | Member of Board of Directors |
| Stephen Sherwin | Member of Board of Directors |
| Caroline Dorsa | Member of Board of Directors |
| Jesus Mantas | Member of Board of Directors |
| William Hawkins | Member of Board of Directors |
| William Jones | Member of Board of Directors |
| Michel Vounatsos | Chairman of Managing Board |
| Ginger Gregory | Member of Executive Committee |
| Alphonse Galdes | Member of Executive Committee |
| Michael McDonnell | Member of Executive Committee |
| Rachid Izzar | Member of Executive Committee |
| Susan H. Alexander | Member of Executive Committee |